Point72 Middle East FZE’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-44,767
| Closed | -$167K | – | 350 |
|
|
2023
Q4 | $167K | Sell |
44,767
-146,726
| -77% | -$549K | 0.01% | 594 |
|
|
2023
Q3 | $406K | Buy |
191,493
+125,413
| +190% | +$266K | 0.01% | 451 |
|
|
2023
Q2 | $315K | Buy |
+66,080
| New | +$315K | 0.01% | 499 |
|
|
2023
Q1 | – | Sell |
-39,031
| Closed | -$394K | – | 1248 |
|
|
2022
Q4 | $394K | Buy |
+39,031
| New | +$394K | 0.02% | 435 |
|